Sign in: Staff/Students
The University of Liverpool has signed an access agreement to use the University of Manchester’s Dalton Cumbrian Facility (DCF).
Liverpool is the first university to formally gain access to the DCF which opened in September 2013.
Facilities available at the DCF include a self-shielded Cobalt-60 irradiator and a 5MV Pelletron accelerator capable of providing a beam of 10MeV protrons or 15MeV helium ions.
Professor Eann Patterson, from the University’s School of Engineering, said: “Access to DCF along with the National Nuclear Laboratory’s Central Laboratory and the THOR research reactor at National Tsing Hua University in Taiwan provide a unique set of research opportunities for University staff and post-graduate students in the fields of nuclear science and engineering.”
Researchers from across the University’s Faculty of Science and Engineering will be working on a number of research projects at the DCF. These include innovative gamma ray detection systems; automated formal verification of software and processes; robust design of nuclear systems; catastrophe modelling for decision-making; simulation of filtration systems; and spent fuel disposal operations.
Professor Andrew Sherry, Director of Manchester’s Dalton Nuclear Institute, said: “We are delighted to welcome Liverpool University as a user of the Dalton Cumbrian Facility at a time when nuclear R&D is recognised as a critical component of the UK’s Nuclear Industrial Strategy. We look forward to building a fruitful collaboration in nuclear research and skills development.”
You must be logged in to post a comment.
All recent news
University launches UK first Research Technical Professional Career Pathway
New digital tools use climate data to tackle infectious disease outbreaks
World Cancer Day: A year in research
Eurovision needs you – volunteering opportunities available
Don’t miss the Refreshers Fair!
In a UK first, we've launched a new Research Technical Professional Career Pathway. Technical & research support staff are essential to UK research & innovation, and this scheme aims to improve the career pathways of colleagues in these roles.
A new digital tool will use climate data to help better predict and prepare for infectious disease outbreaks in the Horn of Africa.
Funded by @wellcometrust, the project is led by @LivUni_IVES with partners from Italy, Kenya, Ethiopia, Uganda & Somalia.
Matching medication to DNA leads to 30% fewer side effects, says major international study with Liverpool as the UK trial site. Read more, inc recommendations for patient 'DNA medication pass' here: https://news.liverpool.ac.uk/2023/02/03/matching-medication-to-dna-leads-to-30-fewer-side-effects/